Jean-Pierre Bouiller
Investment Committee Member at Sofimac Régions SAS
Profile
Mr. Jean-Pierre Bouiller has a degree from Ecole Supérieure de Commerce in Clermont-Ferrand (1987).
He subsequently worked in accounting at Fiduciaire de France (Fidex) before joining Sofimac in October 1989.
Initially responsible for a portfolio of diversified investments, he was later entrusted with the management of sector-specific funds before being appointed Portfolio Manager for Sofimac in 1999 and Sofimac Croissance in 2005.
Jean-Pierre Bouiller active positions
| Companies | Position | Start |
|---|---|---|
Sofimac Régions SAS
 Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Investment Committee Member | 2010-06-21 |
Former positions of Jean-Pierre Bouiller
| Companies | Position | End |
|---|---|---|
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Sofimac Régions SAS
Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Finance |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
- Stock Market
- Insiders
- Jean-Pierre Bouiller
